2025-04-012026-03-312026-03-31false13964988Extracellular Ltd2026-07-2471121falseiso4217:GBPxbrli:pure139649882025-03-31139649882026-03-31139649882025-04-012026-03-31139649882024-03-31139649882025-03-31139649882024-04-012025-03-3113964988bus:SmallEntities2025-04-012026-03-3113964988bus:AuditExempt-NoAccountantsReport2025-04-012026-03-3113964988bus:AbridgedAccounts2025-04-012026-03-3113964988bus:PrivateLimitedCompanyLtd2025-04-012026-03-3113964988core:WithinOneYear2026-03-3113964988core:AfterOneYear2026-03-3113964988core:WithinOneYear2025-03-3113964988core:AfterOneYear2025-03-3113964988core:ShareCapital2026-03-3113964988core:SharePremium2026-03-3113964988core:RevaluationReserve2026-03-3113964988core:OtherReservesSubtotal2026-03-3113964988core:RetainedEarningsAccumulatedLosses2026-03-3113964988core:ShareCapital2025-03-3113964988core:SharePremium2025-03-3113964988core:RevaluationReserve2025-03-3113964988core:OtherReservesSubtotal2025-03-3113964988core:RetainedEarningsAccumulatedLosses2025-03-3113964988core:LandBuildings2026-03-3113964988core:PlantMachinery2026-03-3113964988core:Vehicles2026-03-3113964988core:FurnitureFittings2026-03-3113964988core:OfficeEquipment2026-03-3113964988core:NetGoodwill2026-03-3113964988core:IntangibleAssetsOtherThanGoodwill2026-03-3113964988core:ListedExchangeTraded2026-03-3113964988core:UnlistedNon-exchangeTraded2026-03-3113964988core:LandBuildings2025-03-3113964988core:PlantMachinery2025-03-3113964988core:Vehicles2025-03-3113964988core:FurnitureFittings2025-03-3113964988core:OfficeEquipment2025-03-3113964988core:NetGoodwill2025-03-3113964988core:IntangibleAssetsOtherThanGoodwill2025-03-3113964988core:ListedExchangeTraded2025-03-3113964988core:UnlistedNon-exchangeTraded2025-03-3113964988core:LandBuildings2025-04-012026-03-3113964988core:PlantMachinery2025-04-012026-03-3113964988core:Vehicles2025-04-012026-03-3113964988core:FurnitureFittings2025-04-012026-03-3113964988core:OfficeEquipment2025-04-012026-03-3113964988core:NetGoodwill2025-04-012026-03-3113964988core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3113964988core:ListedExchangeTraded2025-04-012026-03-3113964988core:UnlistedNon-exchangeTraded2025-04-012026-03-3113964988core:MoreThanFiveYears2025-04-012026-03-3113964988core:Non-currentFinancialInstruments2026-03-3113964988core:Non-currentFinancialInstruments2025-03-3113964988dpl:CostSales2025-04-012026-03-3113964988dpl:DistributionCosts2025-04-012026-03-3113964988core:LandBuildings2025-04-012026-03-3113964988core:PlantMachinery2025-04-012026-03-3113964988core:Vehicles2025-04-012026-03-3113964988core:FurnitureFittings2025-04-012026-03-3113964988core:OfficeEquipment2025-04-012026-03-3113964988dpl:AdministrativeExpenses2025-04-012026-03-3113964988core:NetGoodwill2025-04-012026-03-3113964988core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3113964988dpl:GroupUndertakings2025-04-012026-03-3113964988dpl:ParticipatingInterests2025-04-012026-03-3113964988dpl:GroupUndertakingscore:ListedExchangeTraded2025-04-012026-03-3113964988core:ListedExchangeTraded2025-04-012026-03-3113964988dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-04-012026-03-3113964988core:UnlistedNon-exchangeTraded2025-04-012026-03-3113964988dpl:CostSales2024-04-012025-03-3113964988dpl:DistributionCosts2024-04-012025-03-3113964988core:LandBuildings2024-04-012025-03-3113964988core:PlantMachinery2024-04-012025-03-3113964988core:Vehicles2024-04-012025-03-3113964988core:FurnitureFittings2024-04-012025-03-3113964988core:OfficeEquipment2024-04-012025-03-3113964988dpl:AdministrativeExpenses2024-04-012025-03-3113964988core:NetGoodwill2024-04-012025-03-3113964988core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3113964988dpl:GroupUndertakings2024-04-012025-03-3113964988dpl:ParticipatingInterests2024-04-012025-03-3113964988dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3113964988core:ListedExchangeTraded2024-04-012025-03-3113964988dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3113964988core:UnlistedNon-exchangeTraded2024-04-012025-03-3113964988core:NetGoodwill2026-03-3113964988core:IntangibleAssetsOtherThanGoodwill2026-03-3113964988core:LandBuildings2026-03-3113964988core:PlantMachinery2026-03-3113964988core:Vehicles2026-03-3113964988core:FurnitureFittings2026-03-3113964988core:OfficeEquipment2026-03-3113964988core:AfterOneYear2026-03-3113964988core:WithinOneYear2026-03-3113964988core:ListedExchangeTraded2026-03-3113964988core:UnlistedNon-exchangeTraded2026-03-3113964988core:ShareCapital2026-03-3113964988core:SharePremium2026-03-3113964988core:RevaluationReserve2026-03-3113964988core:OtherReservesSubtotal2026-03-3113964988core:RetainedEarningsAccumulatedLosses2026-03-3113964988core:NetGoodwill2025-03-3113964988core:IntangibleAssetsOtherThanGoodwill2025-03-3113964988core:LandBuildings2025-03-3113964988core:PlantMachinery2025-03-3113964988core:Vehicles2025-03-3113964988core:FurnitureFittings2025-03-3113964988core:OfficeEquipment2025-03-3113964988core:AfterOneYear2025-03-3113964988core:WithinOneYear2025-03-3113964988core:ListedExchangeTraded2025-03-3113964988core:UnlistedNon-exchangeTraded2025-03-3113964988core:ShareCapital2025-03-3113964988core:SharePremium2025-03-3113964988core:RevaluationReserve2025-03-3113964988core:OtherReservesSubtotal2025-03-3113964988core:RetainedEarningsAccumulatedLosses2025-03-3113964988core:NetGoodwill2024-03-3113964988core:IntangibleAssetsOtherThanGoodwill2024-03-3113964988core:LandBuildings2024-03-3113964988core:PlantMachinery2024-03-3113964988core:Vehicles2024-03-3113964988core:FurnitureFittings2024-03-3113964988core:OfficeEquipment2024-03-3113964988core:AfterOneYear2024-03-3113964988core:WithinOneYear2024-03-3113964988core:ListedExchangeTraded2024-03-3113964988core:UnlistedNon-exchangeTraded2024-03-3113964988core:ShareCapital2024-03-3113964988core:SharePremium2024-03-3113964988core:RevaluationReserve2024-03-3113964988core:OtherReservesSubtotal2024-03-3113964988core:RetainedEarningsAccumulatedLosses2024-03-3113964988core:AfterOneYear2025-04-012026-03-3113964988core:WithinOneYear2025-04-012026-03-3113964988core:Non-currentFinancialInstrumentscore:CostValuation2025-04-012026-03-3113964988core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-04-012026-03-3113964988core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-04-012026-03-3113964988core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-04-012026-03-3113964988core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-04-012026-03-3113964988core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-04-012026-03-3113964988core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3113964988core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3113964988core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3113964988core:Non-currentFinancialInstrumentscore:CostValuation2026-03-3113964988core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-03-3113964988core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-03-3113964988core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-03-3113964988core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-03-3113964988core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-03-3113964988core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-03-3113964988core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-03-3113964988core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-03-3113964988core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3113964988core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3113964988core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3113964988core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3113964988core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3113964988core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3113964988core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3113964988core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3113964988core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3113964988bus:Director12025-04-012026-03-3113964988bus:Director22025-04-012026-03-31

Extracellular Ltd

Registered Number
13964988
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2026

Extracellular Ltd
Company Information
for the year from 1 April 2025 to 31 March 2026

Directors

FLETCHER, Catherine Jane, Dr
Milligan, William Robert

Registered Address

Science Creates Old Market
Midland Road
Bristol
BS2 0JZ

Registered Number

13964988 (England and Wales)
Extracellular Ltd
Statement of Financial Position
31 March 2026

Notes

2026

2025

£

£

£

£

Fixed assets
Intangible assets334,85811,207
Tangible assets4671,806437,438
706,664448,645
Current assets
Debtors548,493418,346
Cash at bank and on hand38,040135,597
586,533553,943
Creditors amounts falling due within one year(715,114)(349,627)
Net current assets (liabilities)(128,581)204,316
Total assets less current liabilities578,083652,961
Creditors amounts falling due after one year(704,704)(597,680)
Net assets(126,621)55,281
Capital and reserves
Called up share capital21
Share premium1,536,124226,679
Other reserves-1,309,445
Profit and loss account(1,662,747)(1,480,844)
Shareholders' funds(126,621)55,281
The financial statements were approved and authorised for issue by the Board of Directors on 24 July 2026, and are signed on its behalf by:
Milligan, William Robert
Director
Registered Company No. 13964988
Extracellular Ltd
Notes to the Financial Statements
for the year ended 31 March 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Separately acquired patents, trademarks and licences are shown at historical cost. Trademarks, licences (including software) and customer-related intangible assets acquired in a business combination are recognised at fair value at the acquisition date. Trademarks, licences and customer-related intangible assets have a finite useful life and are carried at cost less accumulated amortisation and any accumulated impairment losses. Amortisation is provided on patents starting on the date on which the patents are granted so as to write off the cost, less any estimated residual value, over their useful life as follows: Straight line over 20 years
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Straight line (years)
Land and buildings33
Plant and machinery4
Fixtures and fittings10
Finance leases and hire purchase contracts
Assets held under finance leases which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts are capitalised in the balance sheet. They are depreciated over the shorter of their useful lives or the term of the lease.
2.Average number of employees

20262025
Average number of employees during the year2215
3.Intangible assets

Total

£
Cost or valuation
At 01 April 2512,540
Additions24,999
At 31 March 2637,540
Amortisation and impairment
At 01 April 251,332
Charge for year1,349
At 31 March 262,682
Net book value
At 31 March 2634,858
At 31 March 2511,207
4.Tangible fixed assets

Total

£
Cost or valuation
At 01 April 25687,823
Additions449,561
Disposals(45,354)
At 31 March 261,092,031
Depreciation and impairment
At 01 April 25250,385
Charge for year203,930
On disposals(34,091)
At 31 March 26420,225
Net book value
At 31 March 26671,806
At 31 March 25437,438
5.Obligations under finance leases

2026

2025

££
Finance lease and HP contracts225,445154,473